|
|
||||||||
1From the Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan; 2Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland; the 3National Eye Institute and the 4National Institute of Deafness and other Communication Disorders, National Institutes of Health, Bethesda, Maryland.
PURPOSE. To identify the gene responsible for a complex ocular phenotype of late-onset macular degeneration, long anterior zonules (LAZ), and elevated intraocular pressure (IOP) and to study its expression.
METHODS. Ocular examination, visual field, fluorescein angiography, and electrophysiology testing were performed. One affected individual was treated with vitamin A. DNA from 55 family members (UM:H389) was used for linkage, mapping, and mutation analysis. Linkage analysis of macular degeneration and LAZ phenotypes was performed independently. Mutations in candidate genes were screened by sequencing. mRNA expression of CTRP5 and MFRP, which are bicistronic genes, was studied by semiquantitative RT-PCR (qRT-PCR) in various human tissues. CTRP5 expression was also evaluated by in situ hybridization.
RESULTS. Affected members had LAZ detectable by the third decade and/or macular degeneration by the fourth to fifth decade. A six-month treatment with vitamin A shortened dark adaptation considerably in one affected member. Both conditions mapped independently with zero recombination to 11q23, with maximum lod scores of 3.31 for macular degeneration and 5.41 for LAZ. The same CTRP5 missense mutation was identified in all affected individuals. Retinal pigment epithelium (RPE) and ciliary epithelium (CE) showed highest CTRP5 transcript expression, which was also true for MFRP. CTRP5 tissue expression was confirmed by in situ hybridization.
CONCLUSIONS. A single locus at 11q23 is implicated in a complex ocular phenotype involving RPE and CE, tissues of neuroectodermal origin. All individuals with either LAZ and/or macular degeneration carry the same CTRP5 S163R mutation, which is transmitted in autosomal dominant manner.
This article has been cited by other articles:
![]() |
K. Downs, D. N. Zacks, R. Caruso, A. J. Karoukis, K. Branham, B. M. Yashar, M. H. Haimann, K. Trzupek, M. Meltzer, D. Blain, et al. Molecular Testing for Hereditary Retinal Disease as Part of Clinical Care Arch Ophthalmol, February 1, 2007; 125(2): 252 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. A. Mandal, V. Vasireddy, G. B. Reddy, X. Wang, S. E. Moroi, B. R. Pattnaik, B. A. Hughes, J. R. Heckenlively, P. F. Hitchcock, M. M. Jablonski, et al. CTRP5 Is a Membrane-Associated and Secretory Protein in the RPE and Ciliary Body and the S163R Mutation of CTRP5 Impairs Its Secretion Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5505 - 5513. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. A. Mandal, V. Vasireddy, M. M. Jablonski, X. Wang, J. R. Heckenlively, B. A. Hughes, G. B. Reddy, and R. Ayyagari Spatial and Temporal Expression of MFRP and Its Interaction with CTRP5 Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5514 - 5521. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Mandal and R. Ayyagari Complement factor h: spatial and temporal expression and localization in the eye. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 4091 - 4097. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Shu, B. Tulloch, A. Lennon, D. Vlachantoni, X. Zhou, C. Hayward, and A. F. Wright Disease mechanisms in late-onset retinal macular degeneration associated with mutation in C1QTNF5 Hum. Mol. Genet., May 15, 2006; 15(10): 1680 - 1689. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |